OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Epidemiology: Open Access received 3864 citations as per Google Scholar report
Articles published in Epidemiology: Open Access have been cited by esteemed scholars and scientists all around the world. Epidemiology: Open Access has got h-index 22, which means every article in Epidemiology: Open Access has got 22 average citations.
Following are the list of articles that have cited the articles published in Epidemiology: Open Access.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|---|
Total published articles |
40 | 50 | 61 | 62 | 31 | 20 | 29 | 51 | 66 |
Research, Review articles and Editorials |
17 | 40 | 36 | 15 | 17 | 12 | 0 | 0 | 0 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
0 | 2 | 7 | 16 | 2 | 0 | 0 | 0 | 0 |
Conference proceedings |
0 | 5 | 0 | 0 | 0 | 0 | 47 | 64 | 61 |
Citations received as per Google Scholar, other indexing platforms and portals |
413 | 486 | 526 | 526 | 480 | 428 | 271 | 226 | 181 |
Journal total citations count | 3864 |
Journal impact factor | 10.58 |
Journal 5 years impact factor | 10.09 |
Journal cite score | 10.22 |
Journal h-index | 22 |
Journal h-index since 2019 | 18 |
![]() |
The effect of peripheral blood eosinophilia on inflammatory markers in asthmatic patients with lower respiratory tract infections |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Dissemination and Implementation Science |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
A review of the sampling methodology used in studies evaluating the effectiveness of risk minimisation measures in Europe |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Antibiotic Resistance Creating New Epoch |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Opportunistic Diseases as a Consequence of HIV/AIDS |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Effect of European Medicines Agency's regulatory measures on nimesulide utilization in Portugal |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Risk Management for the 21st Century: Current Status and Future Needs |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
SNP Association Mapping across the Extended Major Histocompatibility Complex and Risk of B-Cell Precursor Acute Lymphoblastic Leukemia in Children |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Association of Gel-Forming Mucins and Aquaporin Gene Expression With Hearing Loss, Effusion Viscosity, and Inflammation in Otitis Media With Effusion |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Adaptation for Regulatory Application: A Content Analysis of FDA Risk Evaluation and Mitigation Strategies Assessment Plans (2014â2018) Using RE-AIM |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Genetic Epidemiology of Breast Cancer in Latin America |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Fetal growth and body size genes and risk of childhood acute lymphoblastic leukemia |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Pre/post effectiveness evaluation of updated additional risk minimisation measures for an orphan disease: Myozyme (alglucosidase alfa) Safety Information Packet |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
HLA-DP genetic variation, proxies for early life immune modulation and childhood acute lymphoblastic leukemia risk |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Linking process indicators and clinical/safety outcomes to assess the effectiveness of abatacept (ORENCIA) patient alert cards in patients with rheumatoid arthritis |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Community pharmacistsâ knowledge and perceptions on risk management plans in the Southern Region of Portugal |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Variation in xenobiotic transport and metabolism genes, household chemical exposures, and risk of childhood acute lymphoblastic leukemia |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
Effectiveness of the golimumab educational program in ensuring healthcare professionalsâ awareness of risks described in the European risk management plan |
View at Publisher | View at Google Scholar | View at Indexing | |
![]() |
European Survey of Prescriber Understanding of Risks Associated with Retigabine |
View at Publisher | View at Google Scholar | View at Indexing | |
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals